EyePoint Pharmaceuticals, Inc. — Director's Dealing 2015

Dec 3, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: pSivida Corp. (PSDV)
CIK: 0001314102
Period of Report: 2015-12-01

Reporting Person: Ross Leonard S (Vice President, Finance)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-12-01	Common Stock	M	1050	$1.81	Acquired	1050	Direct
2015-12-01	Common Stock	S	1050	$4.06	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-12-01	Stock Option (Right to Buy)	$1.81	M	1050	Disposed	2019-06-25	Common Stock (1050)	Direct

Footnotes

F1: Shares sold pursuant to a Rule 10b5-1 Sales Plan adopted by the Reporting Person with respect to the Common Stock of the Issuer.

F2: The option was granted on 06/25/2009 and vested in four equal annual installments beginning on the first anniversary of the date of grant.

F3: The price reported in Column 4 is a weighted average price. 450 shares were sold at $4.05 per share, 400 shares were sold at $4.06 per share and 200 shares were sold at $4.07 per share.